Marksans sets sights on EU generics sector
Contract services firm Marksans Pharmaceutical says that the RPS 1bn (€15.4m) acquisition of UK generics group Relonchem will expand its distribution network and build its presence in the European market.
Archives for August 31, 2008
AMRI raises guidance after BMS project moves forward
A milestone payment from Bristol-Myers Squibb for the successful advancement of a project into clinical development, along with strong sales by its contract research and manufacturing services unit, prompted Albany Molecular Research Inc (AMRI) to hike...
PharmEng cuts costs despite tripled turnover
Canada’s PharmEng International almost tripled its turnover in the second quarter, as its acquisition of a Pfizer manufacturing facility at the end of 2007 transformed sales at contract manufacturing facility Keata Pharma.
UCB refocuses and cuts workforce 17%
UCB is moving forward with efforts to focus on CNS disorders and immunology and plans to cut around 2,000 jobs as part of its SHAPE restructuring program.
ACRI bolts on CRO services with Clinesian deal
US trial firm ACRI and contract research organisation (CRO) Clinesian have teamed up to target the pharmaceutical sector’s ever growing demand for integrated clinical development capacity.